Uniquely MammoCare

With so many healthcare providers to choose from, we understand that it must be daunting to make a selection for your special BreastHealth needs. We at MammoCare therefore hope to list here the treatment outcomes that are uniquely the results of the joint efforts of ourselves and our partners. Our aim is to offer state of the art, evidence-based treatment which affords best outcomes for all our patients.

At MammoCare, we are particularly proud of our breast conservation rate. It has been recently demonstrated that survival outcomes for women who have undergone breast conservation treatment are higher than those who underwent mastectomy.1 It has also been shown that on a population basis, higher mastectomy rates result in poorer the survival outcomes.2 Hence, higher breast conservation rates potentially translate to better survival outcomes.

At MammoCare, our breast conservation rate is 85.7%.3 This means that of all the women with breast cancer who are treated at MammoCare, 85.7% do not have their entire breast removed. Internationally, breast conservation rates of 70% have been reported,1 with rates of 29.2% reported locally4 and 29.7% regionally.5 Survival outcomes of patients treated at MammoCare are not significantly different from those reported internationally.

In addition, with the use of certain surgical techniques and the help of dedicated pathologists, repeat operations for breast cancer for women treated for breast cancer at MammoCare is 0.8%.6 Renown international cancer centres have reported repeat operation rates of 6%-14.9% with the help of pathologists doing intraoperative examination of tissue.7-9 Local tertiary healthcare institutions have reported re-operation rates to be 54.3%.10

In summary, at MammoCare, we aim to provide highest survival for breast cancer by maximising breast conservation treatment, enabling as many patients as possible to benefit from it. Secondly, we aim to keep reoperation rates to a minimum. Ultimately, the objective is to offer the Best BreastHealth journey possible. You may wish to consult our staff for more Uniquely MammoCare efforts.

References

  1. Agarwal S, Pappas L, Neumayer L, et al. Effect of Breast Conservation Therapy vs Mastectomy on Disease-Specific Survival for Early-Stage Breast Cancer. JAMA Surg 2014doi:10.1001/jamasurg2013.3049.
  2. Brooks JM, Chrischilles EA, Landrum MB et al. Survival implications associated with variation in mastectomy rates for early-staged breast cancer. Int J Surg Oncol 2012; doi:10.1155/2012/127854
  3. Tan MP, Sitoh NY, Sim AS. Evaluation of eligibility and utilisation of breast conservation treatment in an Asian community. Asian Pac J Cancer Prev 15(11):4683-8
  4. Sim Y, Tan VK, Ho GH et al. Contralateral prophylactic mastectomy in an Asian population: a single institution review. Breast 2014;23:56-62.
  5. Yip CH, Taib NA, Tan GH, et al. (2009) Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery? World J Surg, 33,54-7.
  6. Tan MP, Sitoh NY, Sim AS. The Impact of Intraoperative Frozen Section Analysis for Margin Status in Breast Conservation Surgery in a Private Hospital Setting. International Journal of Breast Cancer 2014 doi.10.1155/2014/715404.
  7. Esbona K, Li ZH, Wilke LG. Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systemic review. Ann Surg Oncol 2012;doi 10.1245/s10434-012-2492-2
  8. Jorns JM, Visscher D, Sabel M, et al.Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates. Am J Clin Pathol 2012;138:657-669.
  9. Fukamachi K, Ishida T, Usami S, et al. Total-circumference intraoperative frozen section analysis reduces margin-positive rate in breast-conservation surgery. Jpn J Clin Oncol 2010;40:513-520.
  10. Chuwa EW, Tan VH, Tan PH et al. Treatment for ductal carcinoma in situ (DCIS) in an Asian population: outcome and prognostic factors. ANZ J Surg 2008; 78: 42-48

Our Locations

Mount Elizabeth Novena Hospital
38 Irrawaddy Road, #06-21
Mount Elizabeth Novena Hospital
Singapore 329563
Phone: (65) 6694 1706

Mount Elizabeth Orchard
3 Mt Elizabeth, #11-02,
Mount Elizabeth Medical Centre
Singapore 228510
Phone: (65) 6734 4880

Consultation Hours

Mon - Fri: 9 am to 12:30pm; 2 pm to 5 pm
Sat: Strictly by Appointment